Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bob S Carter, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Bob Carter and Leonora Balaj.
Connection Strength

2.559
  1. Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis. Cancers (Basel). 2021 Mar 11; 13(6).
    View in: PubMed
    Score: 0.240
  2. TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas. Clin Cancer Res. 2021 01 01; 27(1):169-178.
    View in: PubMed
    Score: 0.233
  3. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas. Adv Biosyst. 2020 12; 4(12):e2000029.
    View in: PubMed
    Score: 0.227
  4. Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma. Cancers (Basel). 2020 May 13; 12(5).
    View in: PubMed
    Score: 0.226
  5. From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers. Methods. 2020 05 01; 177:58-66.
    View in: PubMed
    Score: 0.223
  6. Extracellular Vesicles in Glioblastoma Tumor Microenvironment. Front Immunol. 2019; 10:3137.
    View in: PubMed
    Score: 0.222
  7. Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma. EBioMedicine. 2019 Oct; 48:23-35.
    View in: PubMed
    Score: 0.217
  8. Navigating the Landscape of Tumor Extracellular Vesicle Heterogeneity. Int J Mol Sci. 2019 Mar 18; 20(6).
    View in: PubMed
    Score: 0.209
  9. Liquid biopsy for brain tumors. Expert Rev Mol Diagn. 2017 10; 17(10):943-947.
    View in: PubMed
    Score: 0.188
  10. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Expert Rev Mol Diagn. 2014 May; 14(4):439-52.
    View in: PubMed
    Score: 0.149
  11. An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma. Nat Biomed Eng. 2021 07; 5(7):678-689.
    View in: PubMed
    Score: 0.061
  12. Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients. Cancers (Basel). 2020 Nov 07; 12(11).
    View in: PubMed
    Score: 0.059
  13. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv. 2018 03; 4(3):eaar2766.
    View in: PubMed
    Score: 0.049
  14. Coding and noncoding landscape of extracellular RNA released by human glioma stem cells. Nat Commun. 2017 10 26; 8(1):1145.
    View in: PubMed
    Score: 0.047
  15. Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles. 2015; 4:26533.
    View in: PubMed
    Score: 0.041
  16. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun. 2015 May 11; 6:6999.
    View in: PubMed
    Score: 0.040
  17. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids. 2013 Jul 23; 2:e109.
    View in: PubMed
    Score: 0.035
  18. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012 Dec; 18(12):1835-40.
    View in: PubMed
    Score: 0.034
  19. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17; 12:22.
    View in: PubMed
    Score: 0.032
  20. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip. 2010 Feb 21; 10(4):505-11.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.